Current findings of fMRI in panic disorder: Contributions for the fear neurocircuitry and CBT effects

Expert Review of Neurotherapeutics

Volumn 10, Issue 2, 2010, Pages 291-303

  De Carvalho, Marcele Regine ^a,b   Dias, Gisele Pereira ^a,b   Cosci, Fiammetta ^c   De Melo Neto, Valfrido Leão ^a,d   Bevilaqua, Mário Cesar Do Nascimento ^a   Gardino, Patricia Franca ^a   Nardi, Antonio Egidio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Neuroimunomodulação   (Brazil)

^c UNIVERSITY OF FLORENCE   (Italy)

^d NONE   (Brazil)

Author keywords

Amygdala; Anterior cingulate cortex; Anxiety neurocircuitry; Cognitive behavior therapy; fMRI; Hippocampus; Panic disorder; Prefrontal cortex

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; SEROTONIN AGONIST; SEROTONIN TRANSPORTER;

AMYGDALOID NUCLEUS; ANXIETY DISORDER; AUDITORY STIMULATION; BRAIN STEM; CAUDATE NUCLEUS; CINGULATE GYRUS; COGNITIVE THERAPY; FEAR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; LIMBIC CORTEX; MENTAL DISEASE; MESENCEPHALON; NEUROBIOLOGY; NEUROPATHOLOGY; OXYGEN BLOOD LEVEL; PANIC; PREFRONTAL CORTEX; PSYCHOSOMATIC DISORDER; PUTAMEN; REVIEW; TEMPORAL CORTEX; THALAMUS; VISUAL STIMULATION;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; PANIC DISORDER;

EID: 76249104273     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.09.161     Document Type: Review

References (58)

1. Andreasen NC. Evaluation of brain imaging techniques in mental illness. Ann. Rev. Med. 39, 335-345 (1988).
2. Bremner JD. Brain imaging in anxiety disorders. Expert Rev. Neurother. 4(2), 275-284 (2004).
3. Brambilla P, Barale F, Caverzasi E, Soares JC. Anatomical MRI findings in mood and anxiety disorders. Epidemiol. Psichiatr. Soc. 11(2), 88-100 (2002).
4. Rocha ET, Alves TCTF, Garridoc GEJ, Buchpiguel R, Nitrinid R, Filho GB. Novas técnicas de neuroimagem em psiquiatria: qual o potencial de aplicações na prática clínica? Rev. Bras. Psiquiatr. 23(Suppl. I), 58-60 (2001).
5. Amaro Jr. E, Yamashita H. Aspectos básicos de tomografia computadorizada e ressonância magnética. Rev. Bras. Psiquiatr. 23, 2-3 (2001).
6. Ontiveros A, Fontaine R, Breton G, Elie R, Fontaine S, Déry R. Correlation of severity of panic disorder and neuroanatomical changes on magnetic resonance imaging. J. Neuropsychiatry Clin. Neurosci. 1(4), 404-408 (1989).
7. Fontaine R, Breton G, Déry R, Fontaine S, Elie R. Temporal lobe abnormalities in panic disorder: an MRI study. Biol. Psychiatry 27(3), 304-310 (1990).
8. Vythilingam M, Anderson ER, Goddard A et al. Temporal lobe volume in panic disorder - a quantitative magnetic resonance imaging study. Psychiatry Res. 99(2), 75-82 (2000).
9. Uchida RR, Del-Ben CM, Busatto GF et al. Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. Psychiatry Res. 63(1), 21-29 (2008).
10. Massana J, Mercader JM, Gómez B, Tobeña A, Salamero M. Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage 19(1), 80-90 (2003).
11. Massana G, Serra-Grabulosa JM, Salgado-Pineda P et al. Parahippocampal gray matter density in panic disorder: a voxel-based morphometric study. Am. J. Psychiatry 160(3), 566-568 (2003).
12. Protopopescu X, Pan H, Tuescher O et al. Increased brainstem volume in panic disorder: a voxel-based morphometric study. Neuroreport 17(4), 361-363 (2006).
13. Marchand WR, Lee JN, Healy L et al. An fMRI motor activation paradigm demonstrates abnormalities of putamen activation in females with panic disorder. J. Affect. Disord. 116(1-2), 121-125 (2009).
14. Pfleiderer B, Zinkirciran S, Arolt V, Heindel W, Deckert J, Domschke K. fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder. World J. Biol. Psychiatry 8(4), 269-272 (2007). •• Represents an important contribution by reviewing the recent advances on functional brain imaging studies in psychiatry.
15. Ekrnan P, Friesen W. Pictures of Facial Affect. Consulting Psychologists Press, Palo Alto, CA, USA (1975).
16. Pillay SS, Gruber SA, Rogowska J, Simpson N, Yurgelun-Todd DA. fMRI of fearful facial affect recognition in panic disorder: the cingulate gyrus-amygdala connection. J. Affect. Disord. 94(1-3), 173-181 (2006).
17. Pillay SS, Rogowska J, Gruber SA, Simpson N, Yurgelun-Todd DA. Recognition of happy facial affect in panic disorder: an fMRI study. J. Anxiety Disord. 21(3), 381-393 (2007).
18. Chechko N, Wehrle R, Erhardt A, Holsboer F, Czisch M, Sämann, PG. Unstable prefrontal response to emotional conflict and activation of lower limbic structures in remitted panic disorder. PLOS One 4(5), 1-11 (2009).
19. van den Heuvel OA, Veltman DJ, Groenewegen HJ et al. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch. Gen. Psychiatry 62(8), 922-933 (2005).
20. Maddock RJ, Buonocore MH, Kile SJ, Garrett AS. Brain regions showing increased activation by threat-related words in panic disorder. Neuroreport 14(3), 325-328 (2003).
21. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 158, 1568-1578 (2001).
22. Domschke K, Ohrman P, Braun M et al. Influence of cathecol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res. 163, 13-20 (2008).
23. Schulman R, Griffiths J, Diewold P. Cathecol-O-methyltransferase activity in patients with depressive illness and anxiety states. Br. J. Psychiatry 132, 133-138 (1978).
24. Weinshilboum RM, Otterness DM, Szumlanski CL. Methylation pharmacogenetics: cathecol-O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 39, 19-52 (1999).
25. Simon NM, Emmanuel N, Ballenger J, Worthington JJ, Kinrys G, Korbly B, Farach, FJ, Pollack MH. Bupropion sustained release for panic disorder. Psychopharmacol. Bull. 37, 66-72 (2003).
26. 1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int. J. Neuropsychopharmacol. 9, 349-355 (2006).
27. Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531 (1996).
28. Schunck T, Erb G, Mathis A et al. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. Neuroimage 31(3),1197-1208 (2006).
29. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 157(4), 493-505 (2000). •• Represents an important contribution to the etiological hypothesis of panic disorder.
30. Coplan JD, Lydiard RB. Brain circuits in panic disorder. Biol. Psychiatry 44(12), 1264-1276 (1998).
31. Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J. Med. 73(7), 941-949 (2006).
32. Gazzaniga MS, Ivry RB, Mangun GR. Cognitive Neuroscience: the Biology of the Mind. WW Norton & Company, NY, USA (1998).
33. LeDoux, J. Fear and the brain: where have we been, and where are we going? Biol. Psychiatry 44(12), 1229-1238 (1998).
34. Stein DJ. The neurobiology of panic disorder: toward an integrated model. CNS Spectr. 10(9), 5-13 (2005).
35. De Carvalho MR, Rosenthal M, Nardi AE. The fear circuitry in panic disorder and its modulation by cognitive-behaviour therapy interventions. World J. Biol. Psychiatry (2009) (In press).
36. Clark DM. A cognitive approach to panic. Behav. Res. Ther. 24, 461-470 (1986).
37. Fava GA, Ruini C, Rafanelli C. Sequential treatment of mood and anxiety disorders. J. Clin. Psychiatry 66(11), 1392-1400 (2005).
38. Kumari V. Do psychotherapies produce neurobiological effects? Acta Neuropsychiatrica 18, 61-70 (2006).
39. Beauregard M. Mind does really matter: Evidence from neuroimaging studies of emotional self-regulation, psychotherapy, and placebo effect. Prog. Neurobiol. 81, 218-236 (2007).
40. Frewen PA, Dozois DJA, Lanius RA. Neuroimaging studies of psychological interventions for mood and anxiety disorders: Empirical and methodological review. Clin. Psychol. Rev. 28, 228-246 (2008).
41. Linden DE. Brain imaging and psychotherapy: methodological considerations and practical implications. Eur. Arch. Psychiatry Clin. Neurosci. 258 (5), 71-75 (2008).
42. Sanders MJ, Wiltgen BJ, Fanselow MS. The place of the hippocampus in fear conditioning. Eur. J. Pharmacol. 463(1-3), 217-223 (2003).
43. Miller LA, Taber KH, Gabbard GO, Hurley RA. Neural underpinnings of fear and its modulation: implications for anxiety disorders. J. Neuropsychiatry Clin. Neurosci. 17(1), 1-6 (2005).
44. Cannistraro PA, Rauch SL. Neural Circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol. Bull. 37(4), 8-25 (2003).
45. De Raedt R. Does neuroscience hold promise for the further development of behavior therapy? The case of emotional change after exposure in anxiety and depression. Scand. J. Psychol. 47, 225-236 (2006). •• Represents an important contribution to the understanding of the neurobiological hypothesis of psychotherapy mechanisms of change.
46. Roffman JL, Marci CD, Glick DM, Dougherty DD, Rauch SL. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol. Med. 35, 1385-1398 (2005).
47. McNally RJ. Mechanisms of exposure therapy: How neuroscience can improve psychological treatments for anxiety disorders. Clin. Psychol. Rev. 27, 750-759 (2007).
48. Prasko J, Horácek J, Záleský R et al. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol. Lett. 25(5), 340-348 (2004).
49. Sakai Y, Kumano H, Nishikawa M et al. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive - behavioral therapy. Neuroimage 33(1), 218-226 (2006).
50. Ulrich-Lai YM, Herman JP. Neural regulation of encodrine and autonomic stress response. Nat. Rev. 10, 397-409 (2009).
51. Joëls M, Baram TZ. The neuro-symphony of stress. Nat. Rev. 10, 459-466 (2009).
52. Bremner D, Charney DS. Neural circuits in fear and anxiety. In: Textbook of Anxiety Disorders (Second Edition). Stein DJ, Hollander E, Rothbaum BO (Eds). American Psychiatric Publishing Inc., Washington, DC, USA (2010).
53. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. 10, 434-445 (2009).
54. Arnsten AFT. Stress signaling pathways that impair prefrontal cortex structure and function. Nat. Rev. 10, 410-422 (2009).
55. Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nat. Rev. 10, 423-433 (2009).
56. Yoo HK, Kim MJ, Kim SJ et al. Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study. Eur. J. Neurorsci. 22, 2089-2094 (2005).
57. Yalachkov Y, Kaiser J, Naumer MJ. Brain regions related to tool use and action knowledge reflect nicotine dependence. J. Neurosci. 29(15), 4922-4929 (2009).
58. Thoeringer CK, Ripke S, Unschuld PG et al. The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. J. Neural Transm. 116(6), 649-657 (2009).